US2017159105A1PendingUtilityA1
Enzyme Assays on a Droplet Actuator
Est. expiryMar 22, 2027(~0.7 yrs left)· nominal 20-yr term from priority
Inventors:Allen E. EckhardtCarrie GrahamRamakrishna SistaVamsee K. PamulaTheodore WingerTong WangYalin XiongNing WuSanjay SahaGajendrasinh RaoljiRaveendra Dayam
C07H 15/203G01N 21/6452G01N 2333/938C07D 311/20B01L 3/502784B01L 2300/0816G01N 2333/926C07D 413/12C07D 405/12C12Q 1/34C07H 17/075C07D 311/16C12Q 1/54C12Q 1/25G01N 33/5438C12Y 302/01023B01L 2400/043B01L 2400/0427B01L 2300/0654B01L 2300/18C07D 311/18G01N 2800/04C12Q 1/44G01N 2333/916C12Q 1/40
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention is directed to droplet actuator devices and assay methods. The invention includes assay methods of conducting an assay comprising combining a sample with an umbelliferyl derivative, wherein the sample potentially comprises an enzyme capable of cleaving the umbelliferyl derivative and where the umbelliferyl derivative comprises an umbelliferyl core modified with one or more modifying moieties.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . An assay for acid β-galactosidase activity, comprising:
(a) combining in oil a sample droplet with a 4-methylumbelliferyl-B-galactose to yield a reaction droplet;
(b) splitting the reaction droplet to yield a first daughter droplet and a second daughter droplet;
(c) combining the first daughter droplet with a stop buffer droplet to yield a first stopped reaction droplet;
(d) incubating the second daughter droplet; and
(e) combining the second daughter droplet with a stop buffer droplet to yield a second stopped reaction droplet.
2 . The method of claim 1 , further comprising measuring 4-methylumbelliferone in the first and second stopped reaction droplets.
3 . The method of claim 1 wherein multiple assays for β-galactosidase activity are performed in parallel.
4 . The method of claim 1 wherein the incubating proceeds for a time which is less than about 24 hours.
5 . The method of claim 1 wherein the incubating proceeds for a time which is less than about 12 hours.
6 . The method of claim 1 wherein the incubating proceeds for a time which is less than about 9 hours.
7 . The method of claim 1 wherein the incubating proceeds for a time which is less than about 6 hours.
8 . The method of claim 1 wherein the incubating proceeds for a time which is less than about 3 hours.
9 . The method of claim 1 wherein the incubating proceeds at about room temperature.
10 . The method of claim 1 wherein the droplets are surrounded by oil.
11 . The method of claim 1 wherein the steps of the method are performed in droplets controlled by a droplet actuator.
12 . The method of claim 1 wherein the droplet actuator controls the steps using electrode mediated droplet operations.
13 . The method of claim 12 wherein the droplet actuator controls the steps using electrowetting mediated droplet operations.
14 . The method of claim 12 wherein the droplet actuator controls the steps using dielectrophoresis mediated droplet operations.
15 . The method of claim 1 wherein the sample comprises a blood sample.
16 . The method of any of claim 15 wherein the blood sample is prepared by a method including an anion reduction step.
17 . The method of any of claim 16 wherein the anion reduction step comprises a dilution step.
18 . The method of any of claim 16 wherein the anion reduction step comprises a precipitation step.
19 . The method of claim 1 wherein the sample comprises a plasma sample.
20 . The method of claim 19 wherein the plasma sample is diluted from about 1:2 to about 1:15 plasma:buffer.
21 . The method of claim 19 wherein the plasma sample is diluted from about 1:5 to about 1:10 plasma:buffer.
22 . The method of claim 1 wherein the sample is a reconstituted dried blood spot sample.
23 . The method of claim 22 wherein the reconstituted blood sample is reconstituted from a dried blood spot using an extraction volume ranging from about 25 to about 150 μL.
24 . The method of claim 22 wherein the reconstituted blood sample is reconstituted from a dried blood spot using an extraction volume ranging from about 25 to about 100 μL.
25 . The method of claim 22 wherein the reconstituted blood sample is reconstituted from a dried blood spot using an extraction volume ranging from about 25 to about 75 μL.
26 . The method of claim 22 wherein the reconstituted blood sample is reconstituted from a dried blood spot using an extraction volume ranging from about 40 to about 60 μL.
27 . The method of claim 22 wherein the reconstituted blood sample is reconstituted from a dried blood spot using a buffer doped with surfactant.
28 . The method of claim 27 wherein the surfactant comprises a polysorbate surfactant.
29 . The method of claim 1 , further comprising quantifying released 4-methylumbelliferone or an analog or derivative thereof.
30 . The method of claim 1 wherein the reaction is performed at a temperature ranging from about 25 to about 40° C.
31 . The method of claim 1 wherein the reaction is performed at a temperature ranging from about 30 to about 40° C.
32 . The method of claim 1 wherein the reaction is performed at a temperature ranging from about 36 to about 39° C.Join the waitlist — get patent alerts
Track US2017159105A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.